From January 1, 2024 to March 31, 2024, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 475,816,819 shares, representing 23.94% for $29,984.88 million under the buyback announced on October 27, 2016.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.12 USD | +2.17% | -0.28% | -19.85% |
02:58pm | Bristol Myers: presents advances in lung cancer | CF |
02/06 | Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.85% | 8.33TCr | |
+40.73% | 74TCr | |
+31.47% | 60TCr | |
-6.30% | 35TCr | |
+15.15% | 32TCr | |
+4.05% | 28TCr | |
+15.51% | 24TCr | |
+9.47% | 21TCr | |
-5.32% | 21TCr | |
+6.17% | 16TCr |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Tranche Update on Bristol-Myers Squibb Company's Equity Buyback Plan announced on October 27, 2016.